Popular Business News Stories, Latest Headline News

Unitaid, CHAI, and Wits RHI have signed a groundbreaking deal with Dr. Reddy’s to increase access to the HIV prevention medication lenacapavir at an affordable price in low- and middle-income countries.

A groundbreaking agreement has been reached to make a revolutionary HIV prevention treatment, lenacapavir, more affordable and accessible to low- and middle-income countries. The treatment, which is nearly 100% effective, will be available at a cost of $40 per person...
Popular Business News Stories, Latest Headline News

ResearchAndMarkets.com Releases 2025-2030 India Active Pharmaceutical Ingredients (API) Industry Report, Featuring Aurobindo, Divi’s, Dr. Reddy’s, GSK, Lupin, Novartis, Pfizer, Sanofi, Sun Pharma, and Boehringer Ingelheim in Competitive Analysis

The active pharmaceutical ingredients (API) industry in India is expected to experience significant growth, with a projected value of INR 1.82 trillion by 2030, expanding at a compound annual growth rate (CAGR) of 8.26% during the 2025-2030 period. In 2023, the...